BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 16437504)

  • 1. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Clerihew L; Austin N; McGuire W
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Austin N; McGuire W
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003850. PubMed ID: 23633315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Cleminson J; Austin N; McGuire W
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003850. PubMed ID: 26497056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2013 Mar; (3):CD003478. PubMed ID: 23543519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Cleminson J; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003478. PubMed ID: 26497202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (4):CD002033. PubMed ID: 12519566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    McGuire W; Clerihew L; Austin N
    Cochrane Database Syst Rev; 2003; (1):CD003850. PubMed ID: 12535489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2000; (4):CD000026. PubMed ID: 11034669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    McGuire W; Clerihew L; Austin N
    Cochrane Database Syst Rev; 2004; (1):CD003850. PubMed ID: 14974040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis.
    Ho KM; Rochford SA; John G
    Crit Care Med; 2005 Oct; 33(10):2383-92. PubMed ID: 16215396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (2):CD000026. PubMed ID: 12076377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.